MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
Saved in:
| Title: | MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. |
|---|---|
| Authors: | Sun Y; Department of Medical Oncology, Qilu Hospital of Shandong University, Qingdao, China. 654985219@qq.com., Cao FL, Qu LL, Wang ZM, Liu XY |
| Source: | European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2019 Feb; Vol. 23 (4), pp. 1459-1467. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Verduci Country of Publication: Italy NLM ID: 9717360 Publication Model: Print Cited Medium: Internet ISSN: 2284-0729 (Electronic) Linking ISSN: 11283602 NLM ISO Abbreviation: Eur Rev Med Pharmacol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 30840267 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sun+Y%22">Sun Y</searchLink>; Department of Medical Oncology, Qilu Hospital of Shandong University, Qingdao, China. 654985219@qq.com.<br /><searchLink fieldCode="AU" term="%22Cao+FL%22">Cao FL</searchLink><br /><searchLink fieldCode="AU" term="%22Qu+LL%22">Qu LL</searchLink><br /><searchLink fieldCode="AU" term="%22Wang+ZM%22">Wang ZM</searchLink><br /><searchLink fieldCode="AU" term="%22Liu+XY%22">Liu XY</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229717360%22">European review for medical and pharmacological sciences</searchLink> [Eur Rev Med Pharmacol Sci] 2019 Feb; Vol. 23 (4), pp. 1459-1467. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Verduci%22">Verduci </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>9717360 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2284-0729 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211283602%22">11283602 </searchLink><i>NLM ISO Abbreviation: </i>Eur Rev Med Pharmacol Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30840267 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.26355/eurrev_201902_17103 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1459 Titles: – TitleFull: MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sun Y – PersonEntity: Name: NameFull: Cao FL – PersonEntity: Name: NameFull: Qu LL – PersonEntity: Name: NameFull: Wang ZM – PersonEntity: Name: NameFull: Liu XY IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2019 Feb Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 2284-0729 Numbering: – Type: volume Value: 23 – Type: issue Value: 4 Titles: – TitleFull: European review for medical and pharmacological sciences Type: main |
| ResultId | 1 |